Clinical trial

Study of SHR6390 in Renal Insufficiency and Healthy Subjects

NCT05515289

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-12-18

PhasePHASE1

Study timeline

Study start (actual)2022-12-18Date precision: day

Registry last updated2023-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

SHR6390DRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05515289 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.